Skip to main content

Active Pharmaceutical Ingredient Market Size [2022-2028] | to Reach USD 272.44 Billion, with 6.6% CAGR

Written by Customer Service on . Posted in Mergers And Acquisitions.

Key Companies in the Active Pharmaceutical Ingredient Market Research Report Are Aurobindo Pharma, Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Mylan N.V., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Abbott, Biocon, Cipla Inc., Amgen Inc. and other key market players.

Pune, India, Feb. 01, 2022 (GLOBE NEWSWIRE) — The global active pharmaceutical ingredient market size was USD 159.35 billion in 2020. The market is projected to grow from USD 174.17 billion in 2021 to USD 272.44 billion in 2028 at a CAGR of 6.6% in the 2021-2028 period. This information is provided by Fortune Business Insights™, in its report, titled, “Active Pharmaceutical Ingredient Market, 2021-2028.”

According to our expert analysts, the increasing prevalence of chronic diseases and the rising demand for modified medicine, coupled with the advent of novel drug delivery devices are few of the aspects estimated to play a crucial role in improving the active pharmaceutical ingredients market growth during the mentioned timeframe.

Industry Development

March 2021 – Amgen confirmed the acquisition of Rodeo Therapeutics, a biopharmaceutical firm that focuses on developing small molecule therapies. The acquisition will enable Amgen to expand its inflammation APIs portfolio.


Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/active-pharmaceutical-ingredient-api-market-102656


Report Scope & Segmentation

Report Coverage Details
Forecast Period 2021 to 2028
Forecast Period 2021 to 2028 CAGR 6.6%
2028 Value Projection USD 272.44 Billion
Base Year 2020
Market Size in 2020 USD 174.17 Billion
Historical Data for 2017 to 2019
No. of Pages 138
Segments covered Types, synthesis and Geography
Growth Drivers Price Fluctuations in Emerging Nations to Restrict Market Growth
Generic API Segment to Exhibit Strong CAGR during 2021-2028
Growing Prevalence of Chronic Disease to Fuel API Demand


Drivers and Restraints

Strong Demand for Pharmaceutical Drugs to Kindle Market Growth

The prevalence of various chronic diseases is on the rise owing to the upsurge in geriatric population and inactive lifestyles. This is generating an ever growing demand for therapeutic drugs in this market. As per the Indian Brand Equity Foundation’s (IBEF) examination in June 2021, the Indian pharmaceutical sector was responsible for over 50% of the global demand for numerous vaccines, 40% of U.S. generic brand’s demand as well as U.K’s 25% of all medications demand. The aforementioned factors will bolster the active pharmaceutical ingredient market growth.


Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit: https://www.fortunebusinessinsights.com/active-pharmaceutical-ingredient-api-market-102656


COVID-19 Impact

Supply Chain Uncertainty amid COVID-19 to have Adverse Effects on Global Market

The influence of COVID-19 on this market has been adverse owing to the closure of a number of industrial units in China owing to the COVID-19. Moreover, the deficiency of raw materials have also resulted in the termination of workshops in China.

Also, the decline in demand for pharmaceuticals for definite elective procedures have also resulted in the deterioration of the growth of the market in 2020. Pooled together, these aspects directed to an undesirable effect on the global market.

Regional Insights

North America to Proliferate Led by Increasing Pharmaceutical R&D

North America was worth USD 76.77 billion in 2020 and the region is anticipated to be responsible for holding the highest active pharmaceutical ingredient market share of the global market during the predicted period.

The European region is estimated to perceive an optimistic growth during the forecast period owing to the upsurge in resources for research programs along with existence of major market players in this region.


Quick Buy –  Active Pharmaceutical Ingredient Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102656


List of Key Players Covered in the Market Report

  • Teva Pharmaceutical Industries Ltd (Petah Tikva, Israel)
  • AbbVie Inc. (North Chicago, U.S.)
  • Abbott (Abbott Park, U.S.)
  • Aurobindo Pharma (Hyderabad, India)
  • Cipla Inc. (Mumbai, India)
  • Dr. Reddy’s Laboratories Ltd (Hyderabad, India)
  • Sun Pharmaceutical Industries Ltd (Mumbai, India)
  • Amgen Inc. (Thousand Oaks, U.S.)
  • Biocon (Bengaluru, India)
  • Mylan N.V. (Canonsburg, U.S.)
  • Boehringer Ingelheim International GmbH (Ingelheim am Rhein, Germany)


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/active-pharmaceutical-ingredient-api-market-102656


Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Chronic Diseases -2018
    • New Product Launches by Key Players
    • Recent Industry Developments- Partnerships, Mergers, And Acquisitions
    • Therapeutic Applications of the Different Types of Active Pharmaceutical Ingredient
  • Global Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      • Generic API
      • Branded API
    • Market Analysis, Insights and Forecast – By Synthesis
      • Biological API
      • Synthetic API
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Rest of World
  • North America Industry Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Type
      • Generic API
      • Branded API
    • Market Analysis, Insights and Forecast – By Synthesis
      • Biological API
      • Synthetic API
    • Market Analysis, Insights and Forecast – By Country
      • U.S.
      • Canada

Continued…


Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/active-pharmaceutical-ingredient-api-market-102656


About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.